Larsen, J., Hylleberg, B., Ng, K
Weight loss tends to be steady, around 12 pounds per week, requiring patience and long-term dedication
Ozempic is approved for type 2 diabetes (0.25 mg to 2 mg), while Wegovy is approved for chronic weight management (up to 2.4 mg) and to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either overweight or obesity Exenatide extended-release (Bydureon BCise) : Once-weekly injection using microsphere technology Liraglutide (Victoza, Saxenda) : Once-daily injection
Brand names: Ozempic (diabetes), Wegovy (obesity)
Schedule a consultation to explore how MATTR can support your metabolic health, body composition, and long-term wellness.